Viewing StudyNCT00024557

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-05 @ 11:24 AM
Last Modification Date: 2024-10-26 @ 9:06 AM
Study NCT ID: NCT00024557
Status: COMPLETED
Last Update Posted: 2011-06-06
First Post: 2001-09-20
Brief Title: Histologic EffectSafety of PrePost-Operative IL13-PE38QQR in Recurrent Resectable Supratentorial Malignant Glioma Patients
Sponsor: INSYS Therapeutics Inc
Organization: INSYS Therapeutics Inc
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Malignant Astrocytoma
Malignant Glioma
Glioblastoma Multiforme
Anaplastic Astrocytoma
Mixed Oligoastrocytoma
Keywords:
Name View
positive pressure microinfusion View
neurosurgery craniotomy View
convection-enhanced delivery View
CNS interstitial infusion View
recombinant toxins View
malignant glioma recurrent View
intratumoral therapy View